Pharmacometrics and the transition to model-based development.

Pharmacometrics and the transition to model-based development.

Item
http://www.wikidata.org/entity/Q36882462
Population pharmacokinetics and pharmacodynamics of bivalirudin in young healthy Chinese volunteers.Concepts and challenges in quantitative pharmacology and model-based drug development.Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint.The use of clinical utility assessments in early clinical developmentPharmacometrics: a multidisciplinary field to facilitate critical thinking in drug development and translational research settings.The in silico child: using simulation to guide pediatric drug development and manage pediatric pharmacotherapy.Improving productivity with model-based drug development: an enterprise perspective.Role of modelling and simulation: a European regulatory perspective.Personalizing oncology treatments by predicting drug efficacy, side-effects, and improved therapy: mathematics, statistics, and their integration.Basic PK/PD principles of drug effects in circular/proliferative systems for disease modelling.Model-based drug development: strengths, weaknesses, opportunities, and threats for broad application of pharmacometrics in drug development.
P2860

Pharmacometrics and the transition to model-based development.

Item
http://www.wikidata.org/entity/Q36882462
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pharmacometrics and the transition to model-based development.
@en
type
label
Pharmacometrics and the transition to model-based development.
@en
prefLabel
Pharmacometrics and the transition to model-based development.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Pharmacometrics and the transition to model-based development.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698